Oxford Financial Group LTD. LLC Has $107.32 Million Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Oxford Financial Group LTD. LLC lowered its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.5% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 205,612 shares of the medical equipment provider’s stock after selling 11,975 shares during the period. Intuitive Surgical accounts for approximately 7.0% of Oxford Financial Group LTD. LLC’s holdings, making the stock its 4th largest position. Oxford Financial Group LTD. LLC’s holdings in Intuitive Surgical were worth $107,321,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Atala Financial Inc acquired a new stake in Intuitive Surgical during the fourth quarter worth approximately $25,000. Berbice Capital Management LLC acquired a new stake in Intuitive Surgical during the fourth quarter worth approximately $26,000. BankPlus Trust Department acquired a new stake in Intuitive Surgical during the fourth quarter worth approximately $28,000. Kohmann Bosshard Financial Services LLC acquired a new stake in Intuitive Surgical during the fourth quarter worth approximately $31,000. Finally, Decker Retirement Planning Inc. acquired a new stake in Intuitive Surgical during the fourth quarter worth approximately $36,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $491.81 on Friday. The firm’s fifty day moving average price is $563.34 and its two-hundred day moving average price is $531.34. The stock has a market cap of $175.17 billion, a PE ratio of 76.73, a PEG ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00.

Insiders Place Their Bets

In related news, EVP Robert Desantis sold 11,545 shares of the business’s stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now owns 5,224 shares of the company’s stock, valued at $2,607,925.28. The trade was a 68.85 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Brian Edward Miller sold 8,900 shares of the business’s stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the sale, the executive vice president now directly owns 5,758 shares in the company, valued at approximately $2,793,033.06. This represents a 60.72 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 33,754 shares of company stock valued at $17,691,621. 0.90% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on ISRG. Barclays raised their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Robert W. Baird dropped their price target on shares of Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating for the company in a research report on Tuesday. Citigroup lifted their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research report on Friday, January 24th. CICC Research started coverage on shares of Intuitive Surgical in a research report on Monday, January 27th. They issued a “neutral” rating and a $550.00 price target for the company. Finally, Leerink Partners lifted their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average price target of $611.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.